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Summary
We sought to evaluate the direct impact of a new CMR
program on clinical management and decision-making
in patients with cardiomyopathies from our established
Heart Failure program.
Background
CMR provides unique diagnostic and prognostic infor-
mation in patients with cardiomyopathies. Despite this,
widespread uptake of CMR by Heart Failure physicians
has been slow, particularly in the United States. In the
current health care climate, routine use of a new ima-
ging modality like CMR requires evidence for direct
additive impact on clinical management.
Methods
This was a single-center registry from an academic med-
ical center in the United States. The first 200 patients
from a newly established CMR program were enrolled.
All procedures were performed using standardized
SCMR-recommended protocols on 1.5T and 3T scan-
ners and interpreted by a Level 3 reader. Definitions for
“significant clinical impact” of CMR were pre-defined
and were collected directly from medical records and/or
from patients. Categories of clinical impact included:
new diagnosis, medication change, hospital admission/
discharge, as well as performance or avoidance of inva-
sive procedures (angiography, revascularization, device
therapy or biopsy).
Results
No complications occurred and image quality was good
in 96% of cases. Overall, 36% (n=75) of referrals were
for assessment of cardiomyopathy (ejection fraction
<45%). All cardiomyopathy patients had a recent prior
echocardiogram. In approximately two-thirds (63%) of
these patients, CMR had a significant impact on clinical
management and decision-making. This included an
entirely new diagnosis in 23% of cases and a change in
medication management in 15%. Anticoagulation was
stopped in 5% and started in 3%. CMR results directly
led to angiography in 7% and to the performance of per-
cutaneous coronary intervention in 7%. Bypass-surgery
was performed in 4% and avoided in 9% directly as a
result of CMR findings. Likewise, defibrillator placement
was performed in 5% and avoided in 4%.
Conclusions
CMR makes a significant impact on clinical manage-
ment and decision-making in cardiomyopathy patients
from an established Heart Failure program. It led to a
significant change in clinical management in 63% of
patients referred for assessment of cardiomyopathy. This
additive impact was seen despite widespread use of
echocardiography and other imaging tests in this patient
group. This study lends support to the growing use of
CMR by Heart Failure programs in the United States.
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